TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma

Published:2021-08-13 Issue:10 Volume:9 Page:1202-1213
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Hodi F. Stephen,Wolchok Jedd D.^ORCID,Schadendorf Dirk^ORCID,Larkin James,Long Georgina V.^ORCID,Qian Xiaozhong,Saci Abdel,Young Tina C.,Srinivasan Sujaya^ORCID,Chang Han,Tang Hao,Wind-Rotolo Megan^ORCID,Rizzo Jasmine I.,Jackson Donald G.^ORCID,Ascierto Paolo A.^ORCID

Funder

Bristol Myers Squibb

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The political stakes of cancer epistemics;Social Science & Medicine;2024-10

2. A Complete Response in a Metastatic Melanoma Patient After a Single Dose of Dual Checkpoint Inhibitors Blockade Could Be Predictable: A Case Report;Cureus;2024-09-12

3. Molecular Susceptibility and Treatment Challenges in Melanoma;Cells;2024-08-20

4. Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden;Journal for ImmunoTherapy of Cancer;2024-08

5. Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab;npj Precision Oncology;2024-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP